Ph
Pharmacyclics (AbbVie)
Sunnyvale CAFounded 1991500 employees
Private CapbiotechAcquiredHematology
Platform: Imbruvica BTK
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sovafutibatinib | PHA-7161 | Phase 1 | 2 | BCL-2 | Huntington's | ||
| Niratuximab | PHA-3846 | Phase 1 | 1 | BTK | NMOSDPAH |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)